Cédric-Olivier Turrin

Cédric-Olivier Turrin is director of research at LCC CNRS. His research focuses on the design of hyperbranched phosphorus-containing architectures, including dendrimers, and their use in biomedicine and nanosciences. He cofounded IMD-Pharma SAS in 2016, has coauthored or authored more than 80 articles, 1 book, and 7 book chapters, and holds 5 patents.